Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: August 2017

NFL to Make $40 Million Available for Medical Research; A Board Will Evaluate Proposals

New York, NY, August 31, 2017 — Barry Wilner of the Associated Press reports that, a year after the NFL pledged $100 million in support of independent medical research and engineering advancements, a huge chunk of that soon will be awarded to such research, primarily dedicated to neuroscience.

A Scientific Advisory Board assembled by the NFL is set to launch its program to solicit and evaluate research proposals for funding.

The board, comprised of independent experts, doctors, scientists and clinicians, and chaired by retired U.S. Army General Peter Chiarelli, will provide direction for the $40 million allocated under the league’s initiative. Continue reading

NJ EDA to Make Additional Lab Space Available for State’s Biotechnology Companies

Trenton, NJ, August 31, 2017 — The New Jersey Economic Development Authority (EDA) on August 17 announced it will again expand its successful incubator program with the creation of the Biotechnology Development Center (BDC) on the 50-acre Technology Centre of New Jersey research park in North Brunswick.

The BDC will offer suites of intermediate lab and office space from 3,400 to 10,000 square feet for emerging life sciences companies including those that have outgrown incubator space and other early stage companies looking to expand.

More than 32,600 square feet of new space is now available at the BDC. Continue reading

Rutgers Cancer Institute Research Dr. Jennifer Tsui Receives $729K American Cancer Society Grant

Dr. Jennifer Tsui

New Brunswick, NJ, August 30, 2017 — Jennifer Tsui, PhD, a researcher at Rutgers Cancer Institute of New Jersey, has been awarded a $729,000 Mentored Research Scholar Grant in Applied and Clinical Research from the American Cancer Society to further explore health care delivery and care transitions for underserved cancer patients.

The award supports investigators who are in the early stages of their career in becoming independent researchers as either clinician scientists or cancer control and prevention investigators.

Despite evidence that vulnerable populations often receive poor quality care, few studies have focused on understanding the underlying health care processes that contribute to suboptimal cancer care or poor transitions between primary care and oncology care. Continue reading

Accenture Opens Innovation Center in Florham Park; Helping Clients Explore Business Applications of 3D Printing, Virtual Reality, Robotics and More

Florham Park, NJ, August 29, 2017 — Senior correspondent Brenda Flanagan reported on “NJTV News” that there’s a 3-D printer hard at work in Accenture’s newest innovation center.

The just-opened Florham Park facility uses cutting edge tools to help solve business dilemmas. It turns out, this gadget can save time and money in unexpected places said Jenn Stefanowicz, associate manager for digital acceleration capability at Accenture. Continue reading

Hackensack Meridian and NJ Innovation Institute Cut Ribbon on Agile Strategies Lab, First Health Care Incubator in State

Newark, NJ, August 28, 2017 — Anjalee Khemlani reports on NJBIZ that Agile Strategies Lab — a partnership between Hackensack Meridian Health and New Jersey Innovation Institute (NJII) — held a ribbon-cutting August 15, officially opening the first incubator for health care in New Jersey.

The incubator, which Khemlani first reported on March 9, is located in Newark.  It is being funded by $25 million from the health system and is designed as a space where a “Shark Tank”-like expert panel will hear pitches that aim to solve health care issues. Continue reading

FDA Signs Agreement with European Medicines Agency on Mutual Recognition of Manufacturing Site Inspection

London, August 28, 2017 — The European Commission (EC), the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on August 23 announced they have signed a new confidentiality commitment that allows the U.S. regulator to share non-public and commercially confidential information, including trade secret information relating to medicine inspections with EU regulators.

This confidentiality commitment is a milestone in the ongoing implementation of the mutual recognition of inspections of medicine manufacturers and it aims to strengthen the EU-US relationship. Continue reading

Trump Administration’s R&D Memo Directs Agencies to Emphasizes Basic Science

President Donald Trump

Westerville, OH, August 28, 2017 ― The State Science & Technology Institute (SSTI) blogs that the White House Office of Management and Budget (OMB) on August 17 released a memorandum on research and development (R&D) priorities that directs agencies to prioritize basic science and lower costs in their FY 2019 budget requests.

R&D investments should be made in military superiority, security, prosperity, energy dominance and health.

The memo repeatedly encourages officials to identify, and divest of, research areas where industry is ready to make their own investments toward commercial development. Continue reading

Congress Faces Deadline to Renew Children’s Health Insurance Program

Washington, DC, August 25, 2017 — Rachel Roubein and Nathaniel Weixel today report in The Hill that Congress is approaching a healthcare deadline with enormous stakes for millions of people — and this time it isn’t about Obamacare.

Federal funding for the Children’s Health Insurance Program (CHIP), which serves 9 million low- and middle-income children, is set to expire at the end of September, setting up a crucial deadline for a Congress already grappling with other high-stakes battle.

The looming deadline for CHIP has been overshadowed by the GOP effort to repeal Obamacare, and lawmakers left town for the summer without addressing the issue. Continue reading

HINJ’s ‘Value of Medical Innovation’ Portal Showcases How Life Sciences Is Saving Money — And Lives

New Brunswick, NJ, August 25, 2017 ― The HealthCare Institute of New Jersey (HINJ) continues to update its Value of Medical Innovation, a fact-driven, consumer-friendly digital library that delves into the myriad benefits of research-driven medical innovation, which saves money — and saves lives.

Introduced in September 2015, HINJ’s Value of Medical Innovation presents statistics from a number of resources, including the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), U.S. government sources and various medical research organizations. Continue reading

Opinion: BIO CEO Jim Greenwood on ‘Don’t Let Fear Trump Science – Vaccinate Your Child’

Jim Greenwood

Washington, DC, August 24, 2017Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood wrote the following op-ed that was published in The Philadelphia Inquirer on August 23:

The nice lady had sugar cubes. My classmates and I lined up, single file, at Richboro Elementary School more than half a century ago, waiting for our taste. For a kid, it was a serendipitous moment — our parents were actually ordering us to consume sweets to keep us healthy.

These were no ordinary sugar cubes, though. We were in line to take the new oral polio vaccine. Continue reading